Medical Device News Magazine

B. Braun Launches ACCEL®: Pioneering Interventional Systems

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

B. Braun Interventional Systems Inc. (BIS), a member of the B. Braun Group of Companies, announced today the launch of its new ACCEL® All-Purpose and Biliary Drainage Catheters with TrueGlide® Hydrophilic Coating for percutaneous drainage.

The ACCEL All-Purpose and Biliary Drainage Catheters are designed for optimal patient comfort and clinical care. The catheter features large oval holes designed to maximize fluid drainage volume, while the TrueGlide Hydrophilic Coating helps with a smooth catheter insertion.

Dave Mittl, Vice President of BIS

“We are excited to expand our percutaneous drainage portfolio of products with the ACCEL All-Purpose and Biliary Drainage Catheters, now offering a full-system drainage solution to our customers and bringing value to their drainage procedures. Our comprehensive portfolio of sizes and configurations is designed to meet patients’ various drainage needs to help improve outcomes.”

Over the last two decades, BIS has continuously expanded its percutaneous drainage product offerings, responding to the market needs and bringing solutions focused on increasing the value, safety and efficiency of drainage procedures. The latest addition of the all-purpose and biliary drainage catheters completes the portfolio as a full-system drainage solution, providing convenience and options for percutaneous fluid drainage management.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”